Cite
HARVARD Citation
El Sharkawy, R. et al. (2018). A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B. Alimentary pharmacology & therapeutics. 48 (5), pp. 564-573. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
El Sharkawy, R. et al. (2018). A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B. Alimentary pharmacology & therapeutics. 48 (5), pp. 564-573. [Online].